8‐Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease
Top Cited Papers
- 9 October 2007
- journal article
- technology
- Published by Wiley in Proteomics
- Vol. 7 (20) , 3651-3660
- https://doi.org/10.1002/pmic.200700316
Abstract
An 8‐plex version of an isobaric reagent for the quantitation of proteins using shotgun methods is presented. The 8‐plex version of the reagent relies on amine‐labeling chemistry of peptides similar to 4‐plex reagents. MS/MS reporter ions at 113, 114, 115, 116, 117, 118, 119, and 121 m/z are used to quantify protein expression. This technology which was first applied to a test mixture consisting of eight proteins and resulted in accurate quantitation, has the potential to increase throughput of analysis for quantitative shotgun proteomics experiments when compared to 2‐ and 4‐plex methods. The technology was subsequently applied to a longitudinal study of cerebrospinal fluid (CSF) proteins from subjects undergoing intravenous Ig treatment for Alzheimer's disease. Results from this study identify a number of protein expression changes that occur in CSF after 3 and 6 months of treatment compared to a baseline and compared to a drug washout period. A visualization tool was developed for this dataset and is presented. The tool can aid in the identification of key peptides and measurements. One conclusion aided by the visualization tool is that there are differences in considering peptide‐based observations versus protein‐based observations from quantitative shotgun proteomics studies.Keywords
This publication has 17 references indexed in Scilit:
- Cerebrospinal fluid proteomic biomarkers for Alzheimer's diseaseAnnals of Neurology, 2006
- Intravenous immunoglobulins containing antibodies against -amyloid for the treatment of Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Quantitative and qualitative measure of intralaboratory two‐dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysisElectrophoresis, 2003
- Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's diseaseMolecular Brain Research, 2003
- Shotgun proteomics: integrating technologies to answer biological questions.2003
- Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individualsExperimental Gerontology, 2002
- Proteomics: a technology-driven and technology-limited discovery scienceTrends in Biotechnology, 2001
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Alpha-2 macroglobulin is genetically associated with Alzheimer diseaseNature Genetics, 1998
- Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseasesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998